July 17, 2012 14:46 ET
EasyMed Services Update
TORONTO, ONTARIO--(Marketwire - July 17, 2012) -EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) ("EasyMed" or the "Company") announced today that it has mutually agreed with Biosign Technologies Inc. ("Biosign") to terminate its previously announced transaction to combine operations. The difficult economic climate resulted in Biosign being unable to raise the minimum of $2 million of proceeds to satisfy the financing condition on the transaction. The parties have exchanged releases and no payments are owing by either Biosign or EasyMed.
EasyMed CEO Tejinder Sahota commented that, "EasyMed has agreed to terminate the proposed transaction because certain key financial conditions were not met. We would like to point out however that the distribution agreement between our respective companies is still valid and after the Biosign restructuring we hope to engage in the future on viable business opportunities."
About EasyMed Services, Inc.
EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) is a global medical information technology company delivering a end to end patient care solution through mobile phone/PDA and server technologies offering specialized services and applications for healthcare, insurance and pharmaceutical industries. We are committed to world-class customer service and the protection of our clients' information.
For more information, visit [ www.easymedservices.com ].
This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. These forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances.
The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.